FDA Warns Novo Nordisk Over Alleged Failures to Report Ozempic and Wegovy Side Effects

Agency Cites Serious Violations of Federal Adverse Event Reporting Requirements for Semaglutide Last updated: May 2026  |  Warning letter date: March 5, 2026  |  Drug: Ozempic / Wegovy (semaglutide)  |  Read time: ~9 min In March 2026, the U.S. Food and Drug Administration issued a formal warning letter to Novo Nordisk — the manufacturer of […]